ScreenerHero

BPTHBio-Path Holdings, Inc.

NAS · US · Healthcare · Biotechnology · biopathholdings.com
0.0340USD+0.29%Mkt Cap: 1.71M $P/E: —

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platfo…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.71M $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.89M $
Revenue/Share—
Last Price0.0340 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.04
EPS (TTM)-1.14
EPS (Forward)-4.04
52W Range
0.010018% of range0.1400
52W High0.1400 USD
52W Low0.0100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-6424.68%
ROA-254.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.57M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.54
Current Ratio—
Quick Ratio—
Book Value/Sh-0.8900 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2019
Splits
Last Split1:20
Split DateFeb 23, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.50.30M
Float—
Insiders0.00%
Institutions0.87%
Short Interest
Short Ratio0.4d
Short % Float1.38%
Short % Out.1.38%
Shares Short79.35K
Short (prev mo.)249.95K
Technical
SMA 500.0400 (-15.0%)
SMA 2000.0568 (-40.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)9.44K
Avg Vol (10d)36.71K
Technical Indicators
RSI (14)45.2
MACD-0.0012
MACD Signal-0.0006
MACD Hist.-0.0006
BB Upper0.0428 USD
BB Middle0.0366 USD
BB Lower0.0305 USD
BB Width33.52%
ATR (14)0.0027 USD
Vol Ratio (20d)2.30x